Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Additional treated

<< Previous

Bullboard Posts

Next >>

Comment by rodrabalon Mar 25, 2021 12:25pm

347 Views

Post# 32875789

RE:Additional treated

Boy they are horrible promoters of there stock. Two additional people treated and only mention it as- oooo by the way we have a couple more people in treatment. They should be emphasizing this information and tell us where they are being treated.What about patients 13-14. Where is that news. 180 days is up by now . Why are they keeping everthing so secret. This is really frustrating.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale